TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck – FRONTIERS IN ONCOLOGY

Rubió-Casadevall, J; Cirauqui, BC; Trufero, JM; Serrahima, MP; Castaño, AG; Maseda, AC; Docampo, LI; Segura, PP; Lenza, IC; Calderón, VG; Salvà, JF; Alvarez, CP; Hernandez, I; Morillo, ED; Conde, MC; Galán, JM; Sánchez, MD; Quiroga, V; Ortega, E; Mesia, R – 2023...